McFarlane equates the detailed planning of military operations—like establishing a field hospital—with creating a biotech strategic plan. Both require allocating people, time, and money with a clear, mission-driven focus to achieve complex goals, similar to an 'operational order'.

Unlike large pharma where novel projects compete with established, safer alternatives, biotech startups derive immense power from their singular focus. The "live or die" mentality on a single hard problem forces teams to innovate and persevere through setbacks, which is essential for pushing true scientific boundaries.

To maintain a competitive edge, BridgeBio only pursues programs that are either "first in class" (a novel treatment where none exists) or "best in class" (a demonstrably superior option, like an oral pill versus a daily injection). This strict strategic filter is the core of their entire R&D pipeline selection process.

Instead of competing in a crowded field on standard terms, redefine the competitive landscape. Build your strategy around a game that only you can win, where your firm's unique capabilities—like talent development or add-on execution—become the most important factors for success.

The fundamental purpose of any biotech company is to leverage a novel technology or insight that increases the probability of clinical trial success. This reframes the mission away from just "cool science" to having a core thesis for beating the industry's dismal odds of getting a drug to market.

Faced with China's superior speed and cost in executing known science, the U.S. biotech industry cannot compete by simply iterating faster. Its strategic advantage lies in

A successful biotech is built on a specific hierarchy of priorities. First, establish a clear and compelling vision. Second, bring in the right people with the right mindset. Third, ensure deep, intellectually honest science. Only then should you focus on building the operational infrastructure to support the first three pillars.

For a technical product to succeed, world-class science must be integrated with a high-level business strategy from day one. A founder can't simply build a great technology and expect it to succeed; every facet of the business, from marketing to sales, must be equally high-performing.

Companies often focus too much on the "what" (KPIs, OKRs, tasks). The real strategy lies in deeply understanding and articulating the "why"—the reason the company exists. When the team grasps this fundamental purpose, they don't need detailed instructions on what to do; they can derive the correct actions themselves, enabling effective, autonomous execution.